ANRO (ANRO) Stock Price & Analysis
ANRO (ANRO) rose 0.00% to USD 26.78 as of July 25, 2026 at 03:40 UTC, according to Nexqual real-time market data.
ANRO last closed at USD 26.78; the session ranged USD 25.72–27.89 on volume of 246,746 shares. Market capitalization is —, with a 52-week range of USD 3–28.85 (NYQ). Source: Nexqual, July 25, 2026 at 03:40 UTC.
Key Statistics (as of July 25, 2026 at 03:40 UTC)
| Price | USD 26.78 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 26.78 |
| Open | USD 26.78 |
| Day Range | USD 25.72 – 27.89 |
| 52-Week Range | USD 3 – 28.85 |
| Volume | 246,746 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ANRO)
Nexqual's technical model rates ANRO "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:40 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.44 (neutral) |
| vs SMA50 | Above (USD 23.49) |
| MACD | 0.94 (positive) |
From ANRO's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | USD 7.41 | ▲ 0.14% |
| AVBP | ArriVent BioPharma, Inc. | USD 31.73 | ▲ 4.24% |
| ARTV | Artiva Biotherapeutics, Inc. | USD 10.03 | ▲ 0.1% |
| CGON | CG Oncology, Inc. | USD 69.32 | ▲ 0.01% |
| RAPP | Rapport Therapeutics, Inc. | USD 40.68 | ▼ 1.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:40 UTC. This page is informational and not investment advice.